SPY765.52QQQ738.30+0.05%BTC/USD83,257.38−0.44%DIA514.29+0.27%GLD384.36+0.38%TLT78.59+0.46%
Benzinga

Initiation

SpaceX's Next Big Business Is on the Ground, TD Cowen Says
SpaceX's Next Big Business Is on the Ground, TD Cowen Says
This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
IonQ Stock Wins Analyst Backing Ahead of 2027 Superion Launch
IonQ Stock Wins Analyst Backing Ahead of 2027 Superion Launch
This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
This SpaceX Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
IonQ Stock Wins Analyst Backing Ahead of 2027 Superion Launch
IonQ Stock Wins Analyst Backing Ahead of 2027 Superion Launch
This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
This Tower Semiconductor Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Initiation Recent News

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.
Sandisk Stock Draws Fresh Buy Rating: 'Not Your Father's Sandisk'
Sandisk Stock Draws Fresh Buy Rating: 'Not Your Father's Sandisk'
Rosenblatt initiated Sandisk at Buy with a $2,400 target, citing AI-driven flash demand and surging datacenter revenue.
Rocket Lab Analyst Calls Neutron Launch the ‘Most Material Catalyst’
Rocket Lab Analyst Calls Neutron Launch the ‘Most Material Catalyst’
Rocket Lab (RKLB) stock rises as Cantor Fitzgerald reaffirms Overweight rating and $122 target ahead of key Neutron launch.
This $3 Biotech Could Be Worth $11.45, Analyst Says
This $3 Biotech Could Be Worth $11.45, Analyst Says
William Blair initiates Perspective Therapeutics (NYSE: CATX) at Outperform, citing its strong radiopharmaceutical platform.
Grail Analyst Sees Massive Market Potential with Valuation Headwinds
Grail Analyst Sees Massive Market Potential with Valuation Headwinds
Grail "is a pure play," according to RBC Capital Markets. The company offers a tool for screening malignancies that lack standard protocols.
This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
This Cue Biopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Analysts initiated bullish coverage on TRAX, BGSI, NPCE, CUE and NGVC, assigning Outperform/Buy ratings with price targets from $18 to $120.
This Small Biotech’s Cancer Drug Could Reach $1.3 Billion In Peak Sales
This Small Biotech’s Cancer Drug Could Reach $1.3 Billion In Peak Sales
William Blair initiates Zentalis (ZNTL) at Outperform, citing a $1.3B peak sales potential for lead cancer drug azenosertib.
What's Going On With AMD Stock Wednesday?
What's Going On With AMD Stock Wednesday?
AMD stock gains almost 4%. Discover key MACD momentum shifts, $530 resistance level, and Benzinga Edge ratings.
McDonald's May Focus On Menu Innovation, Remodels In Focus In Medium Term, Say Analysts
McDonald's May Focus On Menu Innovation, Remodels In Focus In Medium Term, Say Analysts
McDonald's Investor Day will detail strategy; analysts cite weak execution, tough conditions, delayed recovery, and remodels
This Brinker Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
This Brinker Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated coverage: Neutral on MCD; Buy on MOVE and EAT; Outperform on SLDB; Equal-Weight on GOLF, with price targets announced.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved